Neogenomics (NEO) Assets Average (2011 - 2026)

Neogenomics (NEO) has reported Assets Average for 16 consecutive years, with $1.4 billion the latest figure, recorded in Q1 2026.

• Assets Average for Q1 2026 came in at $1.4 billion, down 16.46% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.4 billion (down 16.46% YoY), and the FY2025 annual result was $1.5 billion, down 9.68% from the prior year.
• Assets Average was $1.4 billion for Q1 2026 at Neogenomics, down from $1.4 billion in the prior quarter.
• Over five years, Assets Average peaked at $1.8 billion in Q1 2022 and troughed at $1.4 billion in Q1 2026.
• Average Assets Average over 5 years is $1.6 billion, with a median of $1.7 billion recorded in 2024.
• Year-over-year, Assets Average soared 143.47% in 2022 and slipped 16.61% in 2025.
• Over 5 years, Assets Average stood at $1.7 billion in 2022, then decreased by 3.89% to $1.7 billion in 2023, then dropped by 2.39% to $1.6 billion in 2024, then retreated by 16.61% to $1.4 billion in 2025, then declined by 1.03% to $1.4 billion in 2026.
• Per Business Quant data, the three most recent Assets Average figures were $1.4 billion in Q1 2026, $1.4 billion in Q4 2025, and $1.4 billion in Q3 2025.